Abstract

BackgroundUrine has evolved as a promising body fluids in clinical proteomics because it can be easily and noninvasively obtained and can reflect physiological and pathological status of the human body. Many efforts have been made to characterize more urinary proteins in recent years, but few have focused on the analysis throughput and detection reproducibility. Increasing the urine proteomic profiling throughput and reproducibility is urgently needed for discovering potential biomarker in large cohorts.MethodsIn this study, we developed a fast and robust workflow for streamlined urinary proteome analysis. The workflow integrate highly efficient sample preparation technique and urinary specific data-independent acquisition (DIA) approach. The performance of the workflow was systematically evaluated and the workflow was subsequently applied in a proof-of-concept urine proteome study of 21 kidney cancer (KC) patients and 22 healthy controls.ResultsWith this workflow, the entire sample preparation process takes less than 3 h and allows multiplexing on standard centrifuges. Without pre-fractionation, our newly developed DIA method allows quantitative analysis of ~ 1000 proteins within 80 min of MS time (~ 15 samples/day). The quantitation accuracy of the whole workflow was excellent with median CV of 9.1%. The preliminary study on KC identified 125 significantly changed proteins.ConclusionsThe result suggested the feasibility of applying the high throughput workflow in extensive urinary proteome profiling and clinical relevant biomarker discovery.

Highlights

  • Urine has evolved as a promising body fluids in clinical proteomics because it can be and noninvasively obtained and can reflect physiological and pathological status of the human body

  • After protein concentration measurement, ~ 20 ug of protein filtrate were used for subsequent protein digestion on spintip-based proteomic technology (SISPROT)

  • The overall performance of the public resource libraries is still not as good as that of project specific library, they present great potential to be used in future data analysis

Read more

Summary

Introduction

Urine has evolved as a promising body fluids in clinical proteomics because it can be and noninvasively obtained and can reflect physiological and pathological status of the human body. Many efforts have been made to characterize more urinary proteins in recent years, but few have focused on the analysis throughput and detection reproducibility. Urine is an ideal detection objective for identifying biomarkers of urological malignancies as it can be and non-invasively obtained and contains cells and proteins that originate from urogenital system [5, 6]. Recent studies show that urinary proteome has great potential in classification and diagnosis both urogenital and systemic diseases [8,9,10,11,12,13,14]. Urine is a difficult proteomic sample to work with, due to its low protein concentration, high dynamic range of protein expression and high inter-individual variability

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call